UniProt ID | AP2C_HUMAN | |
---|---|---|
UniProt AC | Q92754 | |
Protein Name | Transcription factor AP-2 gamma | |
Gene Name | TFAP2C | |
Organism | Homo sapiens (Human). | |
Sequence Length | 450 | |
Subcellular Localization | Nucleus . | |
Protein Description | Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer.. | |
Protein Sequence | MLWKITDNVKYEEDCEDRHDGSSNGNPRVPHLSSAGQHLYSPAPPLSHTGVAEYQPPPYFPPPYQQLAYSQSADPYSHLGEAYAAAINPLHQPAPTGSQQQAWPGRQSQEGAGLPSHHGRPAGLLPHLSGLEAGAVSARRDAYRRSDLLLPHAHALDAAGLAENLGLHDMPHQMDEVQNVDDQHLLLHDQTVIRKGPISMTKNPLNLPCQKELVGAVMNPTEVFCSVPGRLSLLSSTSKYKVTVAEVQRRLSPPECLNASLLGGVLRRAKSKNGGRSLREKLDKIGLNLPAGRRKAAHVTLLTSLVEGEAVHLARDFAYVCEAEFPSKPVAEYLTRPHLGGRNEMAARKNMLLAAQQLCKEFTELLSQDRTPHGTSRLAPVLETNIQNCLSHFSLITHGFGSQAICAAVSALQNYIKEALIVIDKSYMNPGDQSPADSNKTLEKMEKHRK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Sumoylation | WKITDNVKYEEDCED CEECCCCCCCCCCCC | 53.88 | - | |
10 | Sumoylation | WKITDNVKYEEDCED CEECCCCCCCCCCCC | 53.88 | - | |
11 | Phosphorylation | KITDNVKYEEDCEDR EECCCCCCCCCCCCC | 21.92 | 22210691 | |
22 | Phosphorylation | CEDRHDGSSNGNPRV CCCCCCCCCCCCCCC | 27.04 | 22210691 | |
42 | Ubiquitination | AGQHLYSPAPPLSHT CCCCCCCCCCCCCCC | 34.92 | - | |
70 | Ubiquitination | PYQQLAYSQSADPYS HHHHHCCCCCCCCCC | 16.44 | - | |
72 | Ubiquitination | QQLAYSQSADPYSHL HHHCCCCCCCCCCHH | 28.79 | - | |
112 | Ubiquitination | GRQSQEGAGLPSHHG CCCCCCCCCCCCCCC | 18.65 | - | |
115 | Ubiquitination | SQEGAGLPSHHGRPA CCCCCCCCCCCCCCC | 30.60 | - | |
202 | Ubiquitination | KGPISMTKNPLNLPC CCCCCCCCCCCCCCC | 48.18 | 29967540 | |
211 | Ubiquitination | PLNLPCQKELVGAVM CCCCCCHHHHHCCCC | 60.78 | 21963094 | |
232 | Phosphorylation | CSVPGRLSLLSSTSK ECCCCCHHHCCCCCC | 26.38 | 51163003 | |
235 | Phosphorylation | PGRLSLLSSTSKYKV CCCHHHCCCCCCEEE | 36.54 | 25159151 | |
236 | Phosphorylation | GRLSLLSSTSKYKVT CCHHHCCCCCCEEEE | 36.35 | 29255136 | |
237 | Phosphorylation | RLSLLSSTSKYKVTV CHHHCCCCCCEEEEH | 26.34 | 29255136 | |
238 | Phosphorylation | LSLLSSTSKYKVTVA HHHCCCCCCEEEEHH | 35.62 | 30576142 | |
239 | Ubiquitination | SLLSSTSKYKVTVAE HHCCCCCCEEEEHHH | 49.53 | 21963094 | |
241 | Ubiquitination | LSSTSKYKVTVAEVQ CCCCCCEEEEHHHHH | 34.86 | 22817900 | |
252 | Phosphorylation | AEVQRRLSPPECLNA HHHHHHCCCHHHHCH | 36.28 | 22617229 | |
260 | Phosphorylation | PPECLNASLLGGVLR CHHHHCHHHHHHHHH | 24.05 | 24732914 | |
271 | Phosphorylation | GVLRRAKSKNGGRSL HHHHHHHHCCCCHHH | 30.30 | 10049255 | |
281 | Ubiquitination | GGRSLREKLDKIGLN CCHHHHHHHHHHCCC | 56.40 | - | |
284 | Ubiquitination | SLREKLDKIGLNLPA HHHHHHHHHCCCCCC | 49.46 | - | |
434 | Phosphorylation | YMNPGDQSPADSNKT HCCCCCCCCCCHHHH | 27.13 | 30278072 | |
438 | Phosphorylation | GDQSPADSNKTLEKM CCCCCCCHHHHHHHH | 42.19 | 24732914 | |
440 | Acetylation | QSPADSNKTLEKMEK CCCCCHHHHHHHHHH | 59.44 | 26051181 | |
441 | Phosphorylation | SPADSNKTLEKMEKH CCCCHHHHHHHHHHH | 44.38 | 26074081 | |
444 | Acetylation | DSNKTLEKMEKHRK- CHHHHHHHHHHHCC- | 56.31 | 26051181 | |
444 | Ubiquitination | DSNKTLEKMEKHRK- CHHHHHHHHHHHCC- | 56.31 | - | |
447 | Ubiquitination | KTLEKMEKHRK---- HHHHHHHHHCC---- | 45.25 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
252 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
10 | K | Sumoylation |
| 12072434 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AP2C_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MYC_HUMAN | MYC | genetic | 22371483 | |
KDM5B_HUMAN | KDM5B | genetic | 22371483 | |
MYC_HUMAN | MYC | physical | 22371483 | |
KDM5B_HUMAN | KDM5B | physical | 22371483 | |
UBC9_HUMAN | UBE2I | physical | 12072434 | |
ERBB4_HUMAN | ERBB4 | physical | 20943952 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434, AND MASSSPECTROMETRY. | |
Sumoylation | |
Reference | PubMed |
"Transcription factor AP-2 interacts with the SUMO-conjugating enzymeUBC9 and is sumolated in vivo."; Eloranta J.J., Hurst H.C.; J. Biol. Chem. 277:30798-30804(2002). Cited for: INTERACTION WITH UBE2I, AND SUMOYLATION AT LYS-10. |